Pharma and diagnostic investor Conviction Life files for IPO

Published On 2022-11-27 03:30 GMT   |   Update On 2022-11-27 03:31 GMT

London: Diagnostics and pharmaceutical services technologies investor Conviction Life has filed for an initial public offering to trade on the main market of the London Stock Exchange, the company said on Friday.Conviction Life is targeting gross proceeds of up to 100 million pounds ($121 million) through the issue of up to 100 million ordinary shares.Read also: Yatharth Hospital gets SEBI...

Login or Register to read the full article

London: Diagnostics and pharmaceutical services technologies investor Conviction Life has filed for an initial public offering to trade on the main market of the London Stock Exchange, the company said on Friday.

Conviction Life is targeting gross proceeds of up to 100 million pounds ($121 million) through the issue of up to 100 million ordinary shares.
The company will also undertake a placing programme for up to 250 million ordinary shares and plans to start trading on Dec. 16.

Read also: Concord Biotech files IPO papers with SEBI



Tags:    
Advertisement
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News